These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 18577350)

  • 1. [Lipoatrophy after use of long acting insulin glargine analogue in a 32-year-old patient with type 1 diabetes].
    Dziura M; Wasikowa R
    Pediatr Endocrinol Diabetes Metab; 2008; 14(1):61-3. PubMed ID: 18577350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoatrophy with insulin analogues in type I diabetes.
    Babiker A; Datta V
    Arch Dis Child; 2011 Jan; 96(1):101-2. PubMed ID: 20570843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of lipoatrophy with insulin detemir.
    Del Olmo MI; Campos V; Abellán P; Merino-Torres JF; Piñón F
    Diabetes Res Clin Pract; 2008 Apr; 80(1):e20-1. PubMed ID: 18281121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoatrophy associated with rapid-acting insulin analogues in young patients with type 1 diabetes mellitus.
    Szypowska A; Skórka A; Pańkowska E
    Pediatr Endocrinol Diabetes Metab; 2008; 14(2):117-8. PubMed ID: 18721499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoatrophy associated with the use of insulin analogues: a new case associated with the use of insulin glargine and review of the literature.
    Holstein A; Stege H; Kovacs P
    Expert Opin Drug Saf; 2010 Mar; 9(2):225-31. PubMed ID: 20001763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoatrophy is a thing of the past, or is it?
    Hussein SF; Siddique H; Coates P; Green J
    Diabet Med; 2007 Dec; 24(12):1470-2. PubMed ID: 17976201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, controlled trial comparing twice-a-day insulin glargine mixed with rapid-acting insulin analogs versus standard neutral protamine Hagedorn (NPH) therapy in newly diagnosed type 1 diabetes.
    Hassan K; Rodriguez LM; Johnson SE; Tadlock S; Heptulla RA
    Pediatrics; 2008 Mar; 121(3):e466-72. PubMed ID: 18299307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early hypoglycaemia after accidental intramuscular injection of insulin glargine.
    Karges B; Boehm BO; Karges W
    Diabet Med; 2005 Oct; 22(10):1444-5. PubMed ID: 16176210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of lipoatrophy with Lispro insulin without insulin pump therapy.
    Arranz A; Andia V; López-Guzmán A
    Diabetes Care; 2004 Feb; 27(2):625-6. PubMed ID: 14747261
    [No Abstract]   [Full Text] [Related]  

  • 10. Injection of acidic or neutral insulin and pain: a single-center, prospective, controlled, noninterventional study in pediatric patients with type 1 diabetes mellitus.
    Karges B; Muche R; Riegger I; Moritz M; Heinze E; Debatin KM; Wabitsch M; Karges W
    Clin Ther; 2006 Dec; 28(12):2094-101. PubMed ID: 17296465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin detemir: new drug. A second long-acting insulin analogue: many uncertainties, few advantages.
    Prescrire Int; 2006 Oct; 15(85):163-7. PubMed ID: 17121210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipodystrophy reactions to insulin: effects of continuous insulin infusion and new insulin analogs.
    Radermecker RP; Piérard GE; Scheen AJ
    Am J Clin Dermatol; 2007; 8(1):21-8. PubMed ID: 17298103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Twice-daily compared with once-daily insulin glargine in people with Type 1 diabetes using meal-time insulin aspart.
    Ashwell SG; Gebbie J; Home PD
    Diabet Med; 2006 Aug; 23(8):879-86. PubMed ID: 16911626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoatrophy induced by recombinant human insulin injection.
    Murao S; Hirata K; Ishida T; Takahara J
    Intern Med; 1998 Dec; 37(12):1031-3. PubMed ID: 9932635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin allergy and extensive lipoatrophy in child with type 1 diabetes.
    Beltrand J; Guilmin-Crepon S; Castanet M; Peuchmaur M; Czernichow P; Levy-Marchal C
    Horm Res; 2006; 65(5):253-60. PubMed ID: 16582568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical strategies for controlling peaks and valleys: type 1 diabetes.
    Bolli GB
    Int J Clin Pract Suppl; 2002 Jul; (129):65-74. PubMed ID: 12166610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Picture of the month: insulin-related lipoatrophy].
    Yazdanyar S; Dolmer B; Strauss G
    Ugeskr Laeger; 2011 Aug; 173(33):1968. PubMed ID: 21849139
    [No Abstract]   [Full Text] [Related]  

  • 18. Human insulin-induced lipoatrophy.
    Felner EI
    J Pediatr; 2003 Apr; 142(4):448. PubMed ID: 12712066
    [No Abstract]   [Full Text] [Related]  

  • 19. Lispro insulin-induced lipoatrophy: a new case.
    Al-Khenaizan S; Al Thubaiti M; Al Alwan I
    Pediatr Diabetes; 2007 Dec; 8(6):393-6. PubMed ID: 18036067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections.
    Bode BW
    Clin Ther; 2007; 29 Suppl D():S135-44. PubMed ID: 18191065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.